Biologics Regulatory Top Stories Ortho Regenerative Technologies Announces U.S. IND Clinical Hold Lifted By The FDA & Clearance To Proceed With U.S. Clinical Trial byJosh SandbergDecember 13, 2021
Biologics Regulatory Sports Medicine Ortho Regenerative Technologies Announces Extension of FDA Clinical Hold of ORTHO-R Investigational New Drug Application byJosh SandbergAugust 20, 2021
Biologics Regulatory Ortho Regenerative Technologies Receives Clinical Hold Letter From the U.S. FDA byChris StewartJune 4, 2021
Hospitals FDA Clears SpinalCyte IND Application for Universal Donor Cell Therapy to Treat Lower Back Pain byJosh SandbergNovember 28, 2018
Hospitals SpinalCyte Applies with FDA to Expand Human Clinical Trial of CybroCell™ Dermal Fibroblasts as Investigational New Drug (IND) byJosh SandbergApril 12, 2018
